Case Report
Diagnosis And Treatment of Cerebral Proliferative Angiopathy: Case Report
Balderas-Chairez AT1*, Velázquez-Luis JM1, Hernández-Gurrola MA1, Arellano-Sotelo J1, Balderas-Martinez A2, Sariñana-Navarrete KP3 and Avelar-Garnica FJ1
1Radiology and Imaging Department, Unidad Médica de Alta Especialidad, Hospital de Especialidades “Dr. Bernardo Sepúlveda Gutiérrez”, IMSS, Ciudad de México, México
2Anesthesiology Department, Hospital General de Durango, Secretaria de Salud, Durango, Mexoico
3Anesthesiology Department, Hospital General de Zona, IMSS, Durango, Mexico
Andres Tlacaelel Balderas Chairez, Radiology and Imaging Department, Unidad Médica de Alta Especialidad, Hospital de Especialidades “Dr. Bernardo Sepúlveda Gutiérrez”, IMSS, Ciudad de México, Mexico
Received Date:January 09, 2024; Published Date:January 18, 2024
Abstract
Cerebral proliferative angiopathy (CPA) is an uncommon condition characterized by widespread intravascular shunting. It is crucial to distinguish it from cerebral arteriovenous malformations. This case report focuses on a patient with cerebral proliferative angiopathy, illustrating a well-documented and progressive emergence of hyper vascular shunting extensively affecting the right hemisphere, along with its treatment. The patient’s condition was supported by angiographic and tomographic findings. This case represents the initial documentation of the evolution of cerebral proliferative angiopathy and its corresponding treatment.
Keywords:Cerebral proliferative angiopathy; arteriovenous malformations; cerebral angiography
Abbreviations:CPA: Cerebral Proliferative Angiopathy; MRI: Magnetic Resonance Imaging; MRA: Magnetic Resonance Angiography; AVMs: Arteriovenous Malformations; SVD: Small Vessel Disease
-
R Nhiri, S Bellamqddam, S Amaqdouf , N Elouafi. Cardiotoxicity: An Unusual Case of Methotrexate Overdose. 3(4): 2024. ACCS. MS.ID.000568.
-
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.